Targeted sequencing of RYR2 in a Kazakhstani cohort identified novel missense mutations, highlighting the utility of genetic screening in patients with ventricular arrhythmias.
No takes yet. Share an insight, caveat, or question.
Supports targeted RYR2 sequencing in ventricular arrhythmias; leaves open pathogenicity and screening utility pending validation.
Akilzhanova et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: